Show simple item record

dc.creatorBerghmans, R.en
dc.creatorBerg, M.en
dc.creatorvan den Burg, M.en
dc.creatorter Meulen, R.en
dc.date.accessioned2016-01-09T00:00:51Zen
dc.date.available2016-01-09T00:00:51Zen
dc.date.created2004-04en
dc.date.issued2004-04en
dc.identifierdoi:10.1136/jme.2003.007047en
dc.identifier.bibliographicCitationJournal of Medical Ethics 2004 April; 30(2): 146-150en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Ethical+issues+of+cost+effectiveness+analysis+and+guideline+setting+in+mental+health+care&title=Journal+of+Medical+Ethics+&volume=30&issue=2&spage=146-150&date=2004-04&au=Berghmans,+R.;+Berg,+M.;+van+den+Burg,+M.;+ter+Meulen,+R.en
dc.identifier.urihttp://dx.doi.org/10.1136/jme.2003.007047en
dc.identifier.urihttp://hdl.handle.net/10822/991670en
dc.description.abstractThis article discusses ethical issues which are raised as a result of the introduction of economic evidence in mental health care in order to rationalise clinical practice. Cost effectiveness studies and guidelines based on such studies are often seen as impartial, neutral instruments which try to reduce the influence of non-scientific factors. However, such rationalising instruments often hide normative assumptions about the goals of treatment, the selection of treatments, the role of the patient, and the just distribution of scarce resources. These issues are dealt with in the context of increased control over clinical practice by third parties. In particular, health insurers have a great interest in economic evidence in clinical care settings in order to control access to and quality of (mental) health care. The authors conclude that guideline setting and cost effectiveness analysis may be seen as important instruments for making choices in health care, including mental health care, but that such an approach should always go hand in hand with a social and political debate about the goals of medicine and (mental) health care. This article is partly based on the results of a research project on the normative aspects of guideline setting in psychiatry and cardiology which was conducted under the guidance of the Royal Dutch Medical Association.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:271540en
dc.subjectGoalsen
dc.subjectGuidelinesen
dc.subjectHealthen
dc.subjectHealth Careen
dc.subjectMedicineen
dc.subjectMental Healthen
dc.subjectPsychiatryen
dc.subjectResearchen
dc.subject.classificationNeurosciences and Mental Health Therapiesen
dc.subject.classificationEconomics of Health Careen
dc.titleEthical Issues of Cost Effectiveness Analysis and Guideline Setting in Mental Health Careen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885